Scholars Central

OpinionPublished 14 Sep 2021

New Treatment Options for Lung Cancer

Authors: George Brown

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Non-small cell lung cancer (NSCLC) accounts for around 27% of all cancer-related deaths worldwide, making it a major public health concern. Healing necessitates the complete and permanent removal of the tumour (generally by surgery or radiation [RT]), while significant shrinkage (usually by systemic therapy) may result in long-term disease control. In the absence of treatments, host-tumor interactions, which are major factors in disease progression in the natural history, will have a considerable impact on disease progression, with treatments primarily aiming at shifting the host-tumor balance toward improvement or, if possible, healing. As a result, complete tumoral excision (and, if possible, oligometastatic sickness) remains the preferred treatment, with the goal that the host-immune response will remove microscopic residual disease, maybe with the help of systemic adjuvant medicines.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Molecular Histology & Medical Physiology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Molecular Histology & Medical Physiology
  • SubjectGenetics & Molecular Biology
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “George Brown”